Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

August 05, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Intimation of Board Meeting to be held on Wednesday, August 12, 2026 Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, August 12, 2026, at the registered office of the Company to consider and approve, inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. Further, according to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring, and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from July 01, 2026, and shall remain closed till 48 hours after the announcement/declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2026. This intimation is also being uploaded on the Company's website at https://www.blissgvs.com/ Kindly acknowledge and take on record the same. Thanking you. For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary